Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Max Schnurr

Showing results (21-30 of 63) with videos related to

Pageof 7
Sort By:
Scientific Reports|June 13, 2018
Dying cells expose a nuclear antigen cross-reacting with anti-PD-1 monoclonal antibodiesPhilipp Metzger, Sabrina V Kirchleitner, Lars M Koenig, et al.
Blood|May 1, 2010
Processing and cross-presentation of individual HLA-A, -B, or -C epitopes from NY-ESO-1 or an HLA-A epitope for Melan-A differ according to the mode of antigen deliveryNeil C Robson, Tristan McAlpine, Ashley J Knights, et al.
Blood|October 11, 2003
Role of adenosine receptors in regulating chemotaxis and cytokine production of plasmacytoid dendritic cellsMax Schnurr, Tracey Toy, Amanda Shin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2009
ISCOMATRIX adjuvant induces efficient cross-presentation of tumor antigen by dendritic cells via rapid cytosolic antigen delivery and processing via tripeptidyl peptidase IIMax Schnurr, Martin Orban, Neil C Robson, et al.
Blood|March 22, 2003
ATP gradients inhibit the migratory capacity of specific human dendritic cell types: implications for P2Y11 receptor signalingMax Schnurr, Tracey Toy, Patrizia Stoitzner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2005
Plasmacytoid dendritic cells control TLR7 sensitivity of naive B cells via type I IFNIsabelle Béatrice Bekeredjian-Ding, Isabelle Béatrice Berkeredjian-Ding, Moritz Wagner, et al.
Cancer Immunology, Immunotherapy : CII|January 4, 2014
Concomitant gemcitabine therapy negatively affects DC vaccine-induced CD8(+) T-cell and B-cell responses but improves clinical efficacy in a murine pancreatic carcinoma modelChristian Bauer, Alexander Sterzik, Franz Bauernfeind, et al.
Blood|March 11, 2006
Adaptive functional differentiation of dendritic cells: integrating the network of extra- and intracellular signalsThomas Luft, Elena Rodionova, Eugene Maraskovsky, et al.
Blood|April 29, 2004
Tuning the volume of the immune response: strength and persistence of stimulation determine migration and cytokine secretion of dendritic cellsThomas Luft, Eugene Maraskovsky, Max Schnurr, et al.
Oncoimmunology|October 28, 2015
Targeted activation of melanoma differentiation-associated protein 5 (MDA5) for immunotherapy of pancreatic carcinomaPeter Duewell, Ebba Beller, Sabrina V Kirchleitner, et al.
Pageof 7

Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Scientific Reports|June 13, 2018
Dying cells expose a nuclear antigen cross-reacting with anti-PD-1 monoclonal antibodiesPhilipp Metzger, Sabrina V Kirchleitner, Lars M Koenig, et al.
Blood|May 1, 2010
Processing and cross-presentation of individual HLA-A, -B, or -C epitopes from NY-ESO-1 or an HLA-A epitope for Melan-A differ according to the mode of antigen deliveryNeil C Robson, Tristan McAlpine, Ashley J Knights, et al.
Blood|October 11, 2003
Role of adenosine receptors in regulating chemotaxis and cytokine production of plasmacytoid dendritic cellsMax Schnurr, Tracey Toy, Amanda Shin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2009
ISCOMATRIX adjuvant induces efficient cross-presentation of tumor antigen by dendritic cells via rapid cytosolic antigen delivery and processing via tripeptidyl peptidase IIMax Schnurr, Martin Orban, Neil C Robson, et al.
Blood|March 22, 2003
ATP gradients inhibit the migratory capacity of specific human dendritic cell types: implications for P2Y11 receptor signalingMax Schnurr, Tracey Toy, Patrizia Stoitzner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2005
Plasmacytoid dendritic cells control TLR7 sensitivity of naive B cells via type I IFNIsabelle Béatrice Bekeredjian-Ding, Isabelle Béatrice Berkeredjian-Ding, Moritz Wagner, et al.
Cancer Immunology, Immunotherapy : CII|January 4, 2014
Concomitant gemcitabine therapy negatively affects DC vaccine-induced CD8(+) T-cell and B-cell responses but improves clinical efficacy in a murine pancreatic carcinoma modelChristian Bauer, Alexander Sterzik, Franz Bauernfeind, et al.
Blood|March 11, 2006
Adaptive functional differentiation of dendritic cells: integrating the network of extra- and intracellular signalsThomas Luft, Elena Rodionova, Eugene Maraskovsky, et al.
Blood|April 29, 2004
Tuning the volume of the immune response: strength and persistence of stimulation determine migration and cytokine secretion of dendritic cellsThomas Luft, Eugene Maraskovsky, Max Schnurr, et al.
Oncoimmunology|October 28, 2015
Targeted activation of melanoma differentiation-associated protein 5 (MDA5) for immunotherapy of pancreatic carcinomaPeter Duewell, Ebba Beller, Sabrina V Kirchleitner, et al.
Pageof 7